Artemis Therapeutics, Inc. (ATMS)
Stock Price:
$0.0400 USD
0.0000 (0.00%)
Updated Jul 27, 2020 4:00 PM EDT - End of day
Key Info
| Market Cap |
206,120 |
| Revenue (ttm) |
n/a |
| Net Income (ttm) |
-58,000 |
| Shares Out |
5.15M |
| EPS (ttm) |
-0.02 |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| Dividend |
n/a |
| Dividend Yield |
n/a |
Stock Quote
| Trading Day |
Jul 27, 2020 |
| Last Price |
$0.0400 |
| Previous Close |
$0.0400 |
| Change ($) |
0.0000 |
| Change (%) |
0.00% |
| Day's Open |
0.0360 |
| Day's Range |
0.0360 - 0.0360 |
| Day's Volume |
108 |
| 52-Week Range |
0.0320 - 0.4500 |
More Stats
| Market Cap |
206,120 |
| Enterprise Value |
203,120 |
| Earnings Date (est) |
n/a |
| Ex-Dividend Date |
n/a |
| Shares Outstanding |
5.15M |
| Float |
1.66M |
| EPS (basic) |
-0.013 |
| EPS (diluted) |
-0.02 |
| FCF / Share |
0.00 |
| Dividend |
n/a |
| Dividend Yield |
n/a |
| Earnings Yield |
n/a |
| FCF Yield |
n/a |
| Payout Ratio |
n/a |
| Shares Short |
n/a |
| Short Ratio |
n/a |
| Short % of Float |
n/a |
| Beta |
-6.17 |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| P/FCF Ratio |
n/a |
| PS Ratio |
n/a |
| PB Ratio |
50.52 |
| Revenue |
n/a |
| Operating Income |
-154,000 |
| Net Income |
-58,000 |
| Free Cash Flow |
-10,000 |
| Net Cash |
3,000 |
| Net Cash / Share |
0.00 |
| Gross Margin |
n/a |
| Operating Margin |
n/a |
| Profit Margin |
n/a |
| FCF Margin |
n/a |
| ROA |
-409.31% |
| ROE |
n/a |
| ROIC |
n/a |
Stats based on trailing-twelve-month (ttm) numbers.
Analyst Summary
Analyst Ratings (0)
| Buy |
0 |
| Overweight |
0 |
| Hold |
0 |
| Underweight |
0 |
| Sell |
0 |
Low
175
Current: $0.0400
High
175
Target: 175.00
*Average 12-month price target from 1 stock analysts.
Financial Performance
Financial numbers in millions USD.
Financial Overview
| Year | 2019 | 2018 | 2017 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|
| Revenue | - | - | - | - | 0.24 | 1.29 | 1.06 | 3.75 | 2.81 | 3.01 |
| Revenue Growth | - | - | - | - | -81.06% | 21.39% | -71.69% | 33.29% | -6.7% | - |
| Gross Profit | - | - | - | - | 0.20 | 0.72 | 0.54 | 2.86 | 2.36 | 2.64 |
| Operating Income | -0.17 | -0.77 | -1.04 | -0.16 | -0.35 | -0.35 | -0.96 | -0.27 | 0.09 | 1.59 |
| Net Income | -0.12 | -0.51 | -1.14 | -0.14 | 0.36 | -0.30 | -1.08 | -0.49 | 4.89 | -1.47 |
| Shares Outstanding | 5.15 | 5.15 | 4.89 | 0.86 | 0.86 | 0.86 | 0.86 | 0.84 | 0.74 | 0.33 |
| Earnings Per Share | -0.02 | -0.08 | -0.20 | - | 0.50 | -0.50 | -1.50 | -0.50 | 6.00 | -4.50 |
| Operating Cash Flow | -0.11 | -0.52 | -0.93 | -0.19 | 0.47 | -0.25 | -1.30 | 0.07 | -0.91 | 0.96 |
| Capital Expenditures | - | - | - | - | 0.01 | - | -0.01 | -0.02 | -0.01 | -0.01 |
| Free Cash Flow | -0.11 | -0.52 | -0.93 | -0.19 | 0.48 | -0.25 | -1.30 | 0.04 | -0.92 | 0.96 |
| Cash & Equivalents | 0.00 | 0.01 | 0.53 | 0.66 | 0.85 | 0.37 | 0.61 | 1.91 | 2.18 | 2.80 |
| Total Debt | - | - | - | - | - | - | - | - | - | 8.88 |
| Net Cash / Debt | 0.00 | 0.01 | 0.53 | 0.66 | 0.85 | 0.37 | 0.61 | 1.91 | 2.18 | -6.09 |
| Assets | 0.02 | 0.03 | 0.58 | 0.71 | 0.90 | 0.70 | 1.16 | 2.98 | 2.84 | 3.66 |
| Liabilities | 0.26 | 0.32 | 0.48 | 0.06 | 0.11 | 0.28 | 0.42 | 1.23 | 1.29 | 10.66 |
| Book Value | -0.24 | -0.30 | 0.10 | 0.65 | 0.79 | 0.43 | 0.74 | 1.75 | 1.55 | -7.00 |
Numbers in millions USD, except per-share numbers.
Company Details
| Full Name |
Artemis Therapeutics, Inc. |
| Country |
United States |
Stock Information
| Ticker Symbol |
ATMS |
| Stock Exchange |
US OTC |
| Unique Identifier |
OTCMKTS: ATMS |
Description
Artemis Therapeutics Inc. does not have significant operations. Previously, it was engaged in the development of agents for the prevention and treatment of severe and life-threatening infectious diseases. The company was incorporated in 1997 and is based in New York, New York.